ArticleOncotarget2017

CDK1 promotes nascent DNA synthesis and induces resistance of cancer cells to DNA-damaging therapeutic agents.

Hongwei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.